Belite Bio (BLTE) Tops Q4 EPS by 15c
Tweet
Share
E-mailGet Alerts BLTE Hot Sheet
Join SI Premium – FREE
Belite Bio (NASDAQ: BLTE) reported Q4 EPS of ($0.38), $0.15 better than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Belite Bio (BLTE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Enanta Pharma loses appeal in Pfizer Paxlovid patent case
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
